Coronavirus Disease 2019 (COVID-19) Research
Find a full list of our most recent COVID-19 News on Methodology
Find all of our Covid-19 related research and expertise on Houston Methodist Scholars
The coronavirus disease 2019 (COVID-19) pandemic is an evolving situation. Vaccines and therapeutics have reduced hospitalizations and deaths, but emerging variants remain a concern as the pandemic moves steadily toward the endemic phase. Houston Methodist clinicians continue efforts to vaccinate those in our communities and provide COVID-19 patients with the finest care possible. The Academic Institute remains dedicated to coordinating clinical trials, investigating virus pathogenesis and epidemiology, and pioneering treatments that will further protect our communities and improve patient outcomes.
Omicron – Ongoing Lessons in a Pandemic
Wednesday, June 15, 2022- Omicron Demonstrates the Power and Necessity of Genetic Sequencing in a Pandemic.
SARS-CoV-2 induced chronic oxidative stress and endothelial cell inflammation may increase likelihood of cardiovascular diseases and respiratory failure
Wednesday, March 30, 2022- SARS-CoV-2 infection might induce chronic oxidative stress and endothelial activation resulting in long-term consequences including several cardiovascular complications - even in recovering COVID-19 patients.
A Conversation with Wesley Long, MD, PhD on Omicron
Monday, January 24, 2022- Heather Lander, PhD, at Houston Methodist Academic Institute, sits down with Wesley Long, MD, PhD to discuss topics around Omicron variant and COVID-19.
Houston Methodist-developed algorithm may improve management and outcomes in critically ill COVID-19 patients
Wednesday, January 10, 2022- A novel clinical decision-making algorithm developed at Houston Methodist has the potential to enhance the safety and quality of life of COVID-19 ICU patients via physical therapy intervention.